同步财经603858
步长制药公告，控股子公司步长臻泽股东张建苍拟将其未实缴的步长臻泽0.50%股权转让给张雨博、马晓腾拟将其未实缴的步长臻泽1.00%股权转让给李德义，转让价格均为0元。公司同意放弃上述股权转让的优先受让权。本次转让完成后，公司持有步长臻泽90.00%股权比例不变。步长冠优股东刘安安拟将其未实缴的步长冠优2.00%股权转让给何涛，于海铭拟将其未实缴的步长冠优2.00%股权中的1.00%股权转让给罗文清，另外1.00%股权转让给魏齐文，转让价格均为0元。公司同意放弃上述股权转让的优先受让权。本次转让完成后，公司持有步长冠优90.00%股权比例不变。
时间：2025-07-08 17:41:15 市场： 综合 A股
Buchang Pharma Unit Gets Nod to Market Fasudil Hydrochloride Injection Shandong Buchang Pharmaceuticals' (SHA:603858) unit, Tonghua Guhong Pharmaceutical, received a drug registration certificate from China's National Medical Products Administration for its fasudil hydrochloride injection, according to a Wednesday disclosure on the Shanghai Stock Exchange.The drug is used to prevent cerebral vasospasm and cerebral ischemia symptoms after surgery.The pharmaceutical company is allowed to market the drug until the expiry of the certificate's validation on Sept. 2, 2029.Price (RMB): ¥14.28, Change: ¥-0.050, Percent Change: -0.35%
时间：2024-09-11 12:55:15 市场： 美股 综合 A股